Thailand Women's Health Market Size & Outlook, 2026-2033
Related Markets
Thailand women's health market highlights
- The Thailand women's health market generated a revenue of USD 127.2 million in 2025 and is expected to reach USD 209.8 million by 2033.
- The Thailand market is expected to grow at a CAGR of 6.2% from 2026 to 2033.
- In terms of segment, contraceptives was the largest revenue generating application in 2025.
- Menopause is the most lucrative application segment registering the fastest growth during the forecast period.
Women's health market data book summary
| Market revenue in 2025 | USD 127.2 million |
| Market revenue in 2033 | USD 209.8 million |
| Growth rate | 6.2% (CAGR from 2026 to 2033) |
| Largest segment | Contraceptives |
| Fastest growing segment | Menopause |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, Thailand accounted for 0.2% of the global women's health market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan women's health market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 4,721.0 million by 2033.
Contraceptives was the largest segment with a revenue share of 30.11% in 2025. Horizon Databook has segmented the Thailand women's health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2021 to 2033.
The osteoporosis prevalence among the country’s women aged less than 50 was less than 5%. The prevalence of this disease increased after the age of 50. The following table shows the age-specific prevalence of osteopenia and osteoporosis.
The rising disposable income, increasing awareness about health & wellness, and increasing awareness are among the major factors contributing to the women’s health market growth in the country.
For instance, in April 2023, Fuji Pharma launched Nextstellis (FSN-013) used for the prevention of pregnancy in Thailand. It is introduced to reduce the adverse effects of a combination of drugs containing estrogen.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women's Health Market Scope
Women's Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Apothecus | View profile | 11-50 | Hicksville, New York, United States, North America | https://apothecus.com |
| Blairex Laboratories | View profile | 101-250 | Columbus, Indiana, United States, North America | http://www.blairex.com |
| Agile Therapeutics Inc | View profile | 19 | 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 | https://www.agiletherapeutics.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Thailand women's health market size, by application, 2021-2033 (US$M)
Thailand Women's Health Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
